Effectiveness and safety of a single-tablet regimen of emtricitabine/efavirenz/tenofovir in HIV-1-infected patients in infectious diseases department

被引：0
|
作者：
Xerinda, S. [1 ]
Neves, N. [1 ]
Santos, S. [1 ]
Pineiro, C. [1 ]
Poinhos, R. [2 ]
Soares, J. [1 ]
Serrao, R. [1 ]
Sarmento, A. [1 ]
机构：
[1] Ctr Hosp Sao Joao, Dept Infect Dis, Oporto, Portugal
[2] Univ Porto, Fac Ciencias Nutr & Alimentacao, P-4100 Oporto, Portugal
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2012年 / 15卷
关键词：
D O I：
10.7448/IAS.15.6.18383
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [1] Safety and Efficacy of Coformulated Efavirenz/Emtricitabine/Tenofovir Single-Tablet Regimen in Treatment-Naive Patients Infected with HIV-1
    Gallien, Sebastien
    Flandre, Philippe
    Nga Nguyen
    De Castro, Nathalie
    Molina, Jean-Michel
    Delaugerre, Constance
    JOURNAL OF MEDICAL VIROLOGY, 2015, 87 (02) : 187 - 191
  • [2] Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine
    Nadège Néant
    Florence Gattacceca
    Minh Patrick Lê
    Yazdan Yazdanpanah
    Catherine Dhiver
    Sylvie Bregigeon
    Saadia Mokhtari
    Gilles Peytavin
    Catherine Tamalet
    Diane Descamps
    Bruno Lacarelle
    Caroline Solas
    European Journal of Clinical Pharmacology, 2018, 74 : 473 - 481
  • [3] Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine
    Neant, Nadege
    Gattacceca, Florence
    Le, Minh Patrick
    Yazdanpanah, Yazdan
    Dhiver, Catherine
    Bregigeon, Sylvie
    Mokhtari, Saadia
    Peytavin, Gilles
    Tamalet, Catherine
    Descamps, Diane
    Lacarelle, Bruno
    Solas, Caroline
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (04) : 473 - 481
  • [4] Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjects
    Allavena, C.
    Dailly, E.
    Reliquet, V.
    Bonnet, B.
    Pineau, S.
    Andre-Garnier, E.
    Boutoille, D.
    Bouquie, R.
    Raveleau, A.
    Bouchez, S.
    Billaud, E.
    Raffi, F.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (10) : 2804 - 2808
  • [5] Bioequivalence of efavirenz/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen
    Mathias, Anita A.
    Hinkle, John
    Menning, Mark
    Hui, James
    Kaul, Sanjeev
    Kearney, Brian P.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 167 - 173
  • [6] Patient-Reported Outcomes in Virologically Suppressed, HIV-1-Infected Subjects After Switching to a Simplified, Single-Tablet Regimen of Efavirenz, Emtricitabine, and Tenofovir DF
    Hodder, Sally L.
    Mounzer, Karam
    DeJesus, Edwin
    Ebrahimi, Ramin
    Grimm, Kristy
    Esker, Stephen
    Ecker, Janet
    Farajallah, Awny
    Flaherty, John F.
    AIDS PATIENT CARE AND STDS, 2010, 24 (02) : 87 - 96
  • [7] Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
    DeJesus, Edwin
    Young, Benjamin
    Morales-Ramierz, Javier O.
    Sloan, Louis
    Ward, Douglas J.
    Flaherty, John F.
    Ebrahimi, Ramin
    Maa, Jen-Fue
    Reilly, Karen
    Ecker, Janet
    McColl, Damian
    Seekins, Daniel
    Farajallah, Awny
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 51 (02) : 163 - 174
  • [8] Population Pharmacokinetic Analysis of Darunavir and Tenofovir Alafenamide in HIV-1-Infected Patients on the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen (AMBER and EMERALD Studies)
    Ackaert, Oliver
    McDougall, David
    Perez-Ruixo, Carlos
    Perez-Ruixo, Juan Jose
    Jezorwski, John
    Crauwels, Herta M.
    AAPS JOURNAL, 2021, 23 (04):
  • [9] Population Pharmacokinetic Analysis of Darunavir and Tenofovir Alafenamide in HIV-1-Infected Patients on the Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Single-Tablet Regimen (AMBER and EMERALD Studies)
    Oliver Ackaert
    David McDougall
    Carlos Pérez-Ruixo
    Juan Jose Pérez-Ruixo
    John Jezorwski
    Herta M. Crauwels
    The AAPS Journal, 23
  • [10] Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study
    Gantner, P.
    Reinhart, S.
    Partisani, M.
    Baldeyrou, M.
    Batard, M-L
    Bernard-Henry, C.
    Cheneau, C.
    de Mautort, E.
    Priester, M.
    Fafi-Kremer, S.
    Muret, P.
    Rey, D.
    HIV MEDICINE, 2015, 16 (02) : 132 - 136
12345